Virtual Screening of Cathelicidin-Derived Anticancer Peptides and Validation of Their Production in the Probiotic Limosilactobacillus fermentum KUB-D18 Using Genome-Scale Metabolic Modeling and Experimental Approaches
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms262010077 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Vichugorn Wattayagorn und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Faculty of Science, Kasetsart University, Bangkok 10900, Thailand. Hauptthemen laut MEDLINE: Cathelicidins, Antineoplastic Agents, Probiotics, Limosilactobacillus fermentum. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundamental Fund grant from Kasetsart University, Faculty of Science, Kasetsart University.
Abstract (Originalsprache)
The development of anticancer peptides (ACPs) has emerged as a promising strategy in targeted cancer therapy due to their high specificity and therapeutic potential. Cathelicidin-derived antimicrobial peptides represent a particularly attractive class of ACPs, yet systematic evaluation of their anticancer activity remains limited. In this study, we conducted virtual screening of eight cathelicidin-derived peptides (AL-38, LL-37, RK-31, KS-30, KR-20, FK-16, FK-13, and KR-12) to assess their potential against colon cancer. Among these, LL-37 and FK-16 were identified as the most promising candidates, with LL-37 exhibiting the strongest inhibitory effects on both non-metastatic (HT-29) and metastatic (SW-620) colon cancer cell lines in vitro. To overcome challenges associated with peptide stability and delivery, we employed the probiotic lactic acid bacterium Limosilactobacillus fermentum KUB-D18 as both a biosynthetic platform and delivery vehicle. A genome-scale metabolic model (GEM), iTM505, was reconstructed to predict the strain’s biosynthetic capacity for ACP production. Model simulations identified trehalose, sucrose, maltose, and cellobiose as optimal carbon sources supporting both high peptide yield and biomass accumulation, which was subsequently confirmed experimentally. Notably, L. fermentum expressing LL-37 achieved a growth rate of 2.16 gDW/L, closely matching the model prediction of 1.93 gDW/L (accuracy 89.69%), while the measured LL-37 concentration (26.96 ± 0.08 µM) aligned with predictions at 90.65% accuracy. The strong concordance between in silico predictions and experimental outcomes underscore the utility of GEM-guided metabolic engineering for optimizing peptide biosynthesis. This integrative approach—combining virtual screening, genome-scale modeling, and experimental validation—provides a robust framework for accelerating ACP discovery. Moreover, our findings highlight the potential of probiotic-based systems as effective delivery platforms for anticancer peptides, offering new avenues for the rational design and production of peptide therapeutics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry, Faculty of Science, Kasetsart University, Bangkok 10900, Thailand.
- Department of Zoology, Faculty of Science, Kasetsart University, Bangkok 10900, Thailand.
- Emarica Academy, Bangkok 10900, Thailand.
- Department of Biotechnology, Faculty of Agro-Industry, Kasetsart University, Bangkok 10900, Thailand.
- Kasetsart University International College (KUIC), Kasetsart University, Bangkok 10900, Thailand.
ORCID-Profile: Chomdao Sinthuvanich, Pramote Chumnanpuen
Förderung
- Fundamental Fund grant from Kasetsart University
- Faculty of Science, Kasetsart University
Zitieren
APA
Wattayagorn, V., Mansuwan, T., Angkanawin, K., Sapkaew, C., Sinthuvanich, C., Watthanasakphuban, N., & Chumnanpuen, P. (2025). Virtual Screening of Cathelicidin-Derived Anticancer Peptides and Validation of Their Production in the Probiotic Limosilactobacillus fermentum KUB-D18 Using Genome-Scale Metabolic Modeling and Experimental Approaches. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262010077
Vancouver
Wattayagorn V, Mansuwan T, Angkanawin K, Sapkaew C, Sinthuvanich C, Watthanasakphuban N, et al. Virtual Screening of Cathelicidin-Derived Anticancer Peptides and Validation of Their Production in the Probiotic Limosilactobacillus fermentum KUB-D18 Using Genome-Scale Metabolic Modeling and Experimental Approaches. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262010077
BibTeX
@article{Wattayagorn2025,
author = {Wattayagorn, Vichugorn and Mansuwan, Taratorn and Angkanawin, Krittapas and Sapkaew, Chakkapan and Sinthuvanich, Chomdao and Watthanasakphuban, Nisit and Chumnanpuen, Pramote},
title = {Virtual Screening of Cathelicidin-Derived Anticancer Peptides and Validation of Their Production in the Probiotic Limosilactobacillus fermentum KUB-D18 Using Genome-Scale Metabolic Modeling and Experimental Approaches},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms262010077}
}
EUVIMED